for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Yunnan Baiyao Group Co., Ltd

000538.SZ

Latest Trade

102.80CNY

Change

0.00(0.00%)

Volume

4,086,322

Today's Range

102.40

 - 

103.81

52 Week Range

71.00

 - 

128.00

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
102.80
Open
102.91
Volume
4,086,322
3M AVG Volume
177.54
Today's High
103.81
Today's Low
102.40
52 Week High
128.00
52 Week Low
71.00
Shares Out (MIL)
1,277.40
Market Cap (MIL)
131,317.10
Forward P/E
28.87
Dividend (Yield %)
2.92

Latest Developments

More

Shenzhen Stock Exchange Filing Shows Block Trade Of Yunnan Baiyao Group's Shares Involving 796.6 Mln Yuan

Shenzhen Exchange Filing Shows Block Trade Of Yunnan Baiyao Involving 465.9 Mln Yuan

Yunnan Baiyao Group Says H1 Net Profit Up 9.2% Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Yunnan Baiyao Group Co., Ltd

YUNNAN BAIYAO GROUP CO.,LTD is a China-based company principally engaged in the research, development, manufacture and operation of pharmaceuticals, as well as the wholesaling and retailing of purchased pharmaceuticals. The Company’s products are categorized into traditional Chinese medicine resources, Chinese and western raw medicine materials and preparations, personal care products and raw materials, with Yunnan Baiyao band-aids, Yunnan Baiyao aerosol and Yunnan Baiyao ointment as its main effective products. The Company also provides skin care products and health care products. The Company distributes its products within domestic market and to overseas markets, with domestic market as its main market.

Industry

Biotechnology & Drugs

Contact Info

222 Er' huan Xi Road

KUNMING, YUN

650500

China

+86.871.66324159

http://overseasdivision.yunnanbaiyao.com.cn

Executive Leadership

Minghui Wang

Chairman of the Board, Interim Chief Executive Officer

Fashu Chen

Co-Chairman of the Board

Rong Wang

Vice Chairman of the Board

Wei Wu

Chief Financial Officer, Senior Vice President, Secretary of the Board

Pinyao Yin

Chief Operating Officer, Senior Vice President

Key Stats

1.77 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2017

24.3K

2018

26.7K

2019

29.7K

2020(E)

32.7K
EPS (CNY)

2017

3.020

2018

3.175

2019

3.280

2020(E)

3.599
Price To Earnings (TTM)
29.91
Price To Sales (TTM)
4.20
Price To Book (MRQ)
3.61
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
9.61
LT Debt To Equity (MRQ)
2.70
Return on Investment (TTM)
11.67
Return on Equity (TTM)
9.09

Latest News

Latest News

BRIEF-Yunnan Baiyao Group Plans To Invest 150 Mln Yuan To Set Up International Centre

* SAYS IT PLANS TO INVEST 150 MILLION YUAN ($21.19 million) TO SET UP INTERNATIONAL CENTRE IN SHANGHAI Source text in Chinese: https://bit.ly/3hHh2jo Further company coverage: ($1 = 7.0789 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Yunnan Baiyao Group's 2019 Net Profit Up 19.8% Y/Y

* SAYS 2019 NET PROFIT UP 19.8% Y/Y AT 4.2 BILLION YUAN ($593.23 million) Source text in Chinese: https://bit.ly/3bsSs1O Further company coverage: ($1 = 7.0799 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Yunnan Baiyao Group unit to set up drug sales JV with partner

* Says its wholly owned pharmaceutical unit plans to set up a drug sales JV with partner, with registered capital of 10 million yuan

BRIEF-Pharmaceutical firm Yunnan Baiyao's Q3 net profit up 7.0 percent y/y

Yunnan Baiyao Group Co Ltd * Says Q3 net profit up 7.0 percent y/y Source text in Chinese: http://bit.ly/2yWlnf1 Further company coverage: (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up